-- Continuing to advance lead asset LFB190, a BET inhibitor, targeting EP300 loss--of--function cancers; expect to initiate Phase 1b/2a clinical trial in solid tumors in mid-2026 -- SOUTH SAN ...
SOUTH SAN FRANCISCO, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Leapfrog Bio, a clinical-stage precision oncology company dedicated to discovering and developing novel targeted therapies for cancers ...
-- Continuing to advance lead asset LFB190, a BET inhibitor, targeting EP300 loss‐of‐function cancers; expect to initiate Phase 1b/2a clinical trial in solid tumors in mid-2026 -- SOUTH SAN FRANCISCO, ...
-- Study highlights importance of cancer driver biology in translating results from lab to patients -- -- Findings validate proprietary OncoSLX Platform™, a pharmacogenetic approach that captures the ...
If it feels like everyone is getting the flu, you're not imagining it. This is shaping up to be another severe flu season. That's why it's important to take advantage of every tool we have to keep the ...
Tatiana Schlossberg, the youngest granddaughter of President John F. Kennedy, recently revealed she was diagnosed with terminal acute myeloid leukemia (AML) due to a rare genetic anomaly. In a ...
Many routine laboratory tests continue to be used, despite their limited diagnostic or patient management. Newer biomarkers offer more precise and clinically relevant data at similar costs, with ...
Oct 30 (Reuters) - U.S. President Donald Trump ordered the U.S. military on Thursday to immediately resume testing nuclear weapons after a gap of 33 years, minutes before beginning a meeting with ...
Community driven content discussing all aspects of software development from DevOps to design patterns. This set of AZ-400 practice questions focuses on commonly misunderstood concepts that frequently ...
Community driven content discussing all aspects of software development from DevOps to design patterns. So get ready to test your skills. Good luck on these practice questions, and even better luck ...
A rare genetic mutation that causes a deficiency in an immune regulator called ISG15 is known to make people more vulnerable to some bacterial infections and cause persistent inflammation — but it can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results